Search Articles

View query in Help articles search
e.g. John Smith or 0000-0001-6479-5330

Search Results (1 to 10 of 26 Results)

Download search results: CSV END BibTex RIS

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Adapting and Evaluating an AI-Based Chatbot Through Patient and Stakeholder Engagement to Provide Information for Different Health Conditions: Master Protocol for an Adaptive Platform Trial (the MARVIN Chatbots Study)

Since 2020, led by YM, SA, and B Lebouché, an innovative chatbot named Minimal Anti Retro Viral INterference (now named MARVIN) has been in development for people with HIV. Through a co-design approach involving patients and stakeholders, MARVIN aims to facilitate antiretroviral therapy self-management. The authors’ team subsequently trialed the MARVIN chatbot among people with HIV and validated its usability and acceptability [32].

Yuanchao Ma, Sofiane Achiche, Marie-Pascale Pomey, Jesseca Paquette, Nesrine Adjtoutah, Serge Vicente, Kim Engler, MARVIN chatbots MARVIN chatbots Patient Expert Committee, Moustafa Laymouna, David Lessard, Benoît Lemire, Jamil Asselah, Rachel Therrien, Esli Osmanlliu, Ma'n H Zawati, Yann Joly, Bertrand Lebouché

JMIR Res Protoc 2024;13:e54668

Download Citation: END BibTex RIS

Download PDF Download XML
Article has an altmetric score of 2